首页 正文

Cross-border collaboration, communication, and research frontiers on biologics in chronic rhinosinusitis from 2004 to 2023

{{output}}
Objective: Biologics are considered as a promising novel treatment option for patients with chronic rhinosinusitis who failed with the standard of care (medical therapy and surgical interventions). This bibliometric analysis was ... ...